These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 17000909)
1. Family history and the risk of sudden cardiac death as a manifestation of an acute coronary event. Kaikkonen KS; Kortelainen ML; Linna E; Huikuri HV Circulation; 2006 Oct; 114(14):1462-7. PubMed ID: 17000909 [TBL] [Abstract][Full Text] [Related]
2. Comparison of risk profiles between survivors and victims of sudden cardiac death from an acute coronary event. Kaikkonen KS; Kortelainen ML; Huikuri HV Ann Med; 2009; 41(2):120-7. PubMed ID: 18720091 [TBL] [Abstract][Full Text] [Related]
3. Psychotropic medications and the risk of sudden cardiac death during an acute coronary event. Honkola J; Hookana E; Malinen S; Kaikkonen KS; Junttila MJ; Isohanni M; Kortelainen ML; Huikuri HV Eur Heart J; 2012 Mar; 33(6):745-51. PubMed ID: 21920969 [TBL] [Abstract][Full Text] [Related]
4. Comparison of family history of sudden cardiac death in nonischemic and ischemic heart disease. Hookana E; Junttila MJ; Kaikkonen KS; Ukkola O; Kesäniemi YA; Kortelainen ML; Huikuri HV Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):757-61. PubMed ID: 22787009 [TBL] [Abstract][Full Text] [Related]
5. Birthplace predicts risk for prehospital sudden cardiac death in middle-aged men who migrated to metropolitan area: The Helsinki Sudden Death Study. Tyynela P; Goebeler S; Ilveskoski E; Mikkelsson J; Perola M; Loytonen M; Karhunen PJ Ann Med; 2009; 41(1):57-65. PubMed ID: 18615340 [TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. Tapanainen JM; Lindgren KS; Mäkikallio TH; Vuolteenaho O; Leppäluoto J; Huikuri HV J Am Coll Cardiol; 2004 Mar; 43(5):757-63. PubMed ID: 14998613 [TBL] [Abstract][Full Text] [Related]
7. Prognosis among survivors of primary ventricular fibrillation in the percutaneous coronary intervention era. de Jong JS; Marsman RF; Henriques JP; Koch KT; de Winter RJ; Tanck MW; Wilde AA; Dekker LR Am Heart J; 2009 Sep; 158(3):467-72. PubMed ID: 19699872 [TBL] [Abstract][Full Text] [Related]
8. Association of early repolarization and sudden cardiac death during an acute coronary event. Tikkanen JT; Wichmann V; Junttila MJ; Rainio M; Hookana E; Lappi OP; Kortelainen ML; Anttonen O; Huikuri HV Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):714-8. PubMed ID: 22730409 [TBL] [Abstract][Full Text] [Related]
9. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure. Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711 [TBL] [Abstract][Full Text] [Related]
10. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry. Shiga T; Hagiwara N; Ogawa H; Takagi A; Nagashima M; Yamauchi T; Tsurumi Y; Koyanagi R; Kasanuki H; Heart; 2009 Mar; 95(3):216-20. PubMed ID: 18728065 [TBL] [Abstract][Full Text] [Related]
11. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Albert CM; Chae CU; Rexrode KM; Manson JE; Kawachi I Circulation; 2005 Feb; 111(4):480-7. PubMed ID: 15687137 [TBL] [Abstract][Full Text] [Related]
12. Familial sudden death is an important risk factor for primary ventricular fibrillation: a case-control study in acute myocardial infarction patients. Dekker LR; Bezzina CR; Henriques JP; Tanck MW; Koch KT; Alings MW; Arnold AE; de Boer MJ; Gorgels AP; Michels HR; Verkerk A; Verheugt FW; Zijlstra F; Wilde AA Circulation; 2006 Sep; 114(11):1140-5. PubMed ID: 16940195 [TBL] [Abstract][Full Text] [Related]
13. Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Mäkikallio TH; Barthel P; Schneider R; Bauer A; Tapanainen JM; Tulppo MP; Schmidt G; Huikuri HV Eur Heart J; 2005 Apr; 26(8):762-9. PubMed ID: 15778204 [TBL] [Abstract][Full Text] [Related]
14. Out of hospital sudden cardiac death in Italy: a population-based case-control study. Filippi A; Sessa E; Mazzaglia G; Pecchioli S; Capocchi R; Caprari F; Scivales A; Cricelli C J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):595-600. PubMed ID: 18475128 [TBL] [Abstract][Full Text] [Related]
15. Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction. Nakatani D; Sakata Y; Sato H; Mizuno H; Shimizu M; Suna S; Ito H; Koretsune Y; Hirayama A; Hori M; Am J Cardiol; 2007 Apr; 99(7):885-9. PubMed ID: 17398177 [TBL] [Abstract][Full Text] [Related]
16. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction. Pedersen OD; Abildstrøm SZ; Ottesen MM; Rask-Madsen C; Bagger H; Køber L; Torp-Pedersen C; Eur Heart J; 2006 Feb; 27(3):290-5. PubMed ID: 16267070 [TBL] [Abstract][Full Text] [Related]
17. Sudden out-of-hospital coronary death in patients with no previous cardiac history. An analysis of 221 patients studied at autopsy. Fornes P; Lecomte D; Nicolas G J Forensic Sci; 1993 Sep; 38(5):1084-91. PubMed ID: 8228880 [TBL] [Abstract][Full Text] [Related]
18. Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy. Mäkikallio TH; Barthel P; Schneider R; Bauer A; Tapanainen JM; Tulppo MP; Perkiömäki JS; Schmidt G; Huikuri HV Am J Cardiol; 2006 Feb; 97(4):480-4. PubMed ID: 16461041 [TBL] [Abstract][Full Text] [Related]
19. The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. Wennberg P; Eliasson M; Hallmans G; Johansson L; Boman K; Jansson JH J Intern Med; 2007 Sep; 262(3):360-7. PubMed ID: 17697157 [TBL] [Abstract][Full Text] [Related]
20. High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Anderson RE; Pfeffer MA; Thune JJ; McMurray JJ; Califf RM; Velazquez E; White HD; Rouleau JL; Skali H; Maggioni A; Solomon SD Am Heart J; 2008 Apr; 155(4):706-11. PubMed ID: 18371480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]